Research use only

In stock · depth page

Retatrutide — COA and lot considerations (RUO)

Triple GIP / GLP-1 / glucagon receptor agonist · LY3437943

Retatrutide 10 / 20 / 30 mg · COA note

For laboratory research use only. Not for human or veterinary use, consumption, compounding into a medicine, or injection. Not authorized by Health Canada. Literature on this page is scientific context only. This page is not a licensed drug, a wellness protocol, or a dosing guide.

Match the COA to the sealed vial before the material is released to the bench. This is a process note for research-use-only material, not a potency claim.

What to match before bench release

Pass criteria: the COA header names retatrutide or LY3437943 and matches the purchase order; CAS 2381089-83-2 when the COA lists a registry number; strength 10, 20, or 30 mg matches the vial label; the COA lot equals the sealed vial lot; HPLC area percent is reported for the main peak under a stated method; observed mass or m/z is consistent with the expected peptide; the analysis date is recorded against ship and receipt; the storage statement aligns with the laboratory SOP and the COA.

Photograph or log the vial label (name, milligrams, lot). Archive the lot-matched COA with the invoice number. Quarantine the vial if lot, purity, or mass data disagree with the request record.

Method papers (Carneiro et al. on LC-HRMS; Streuli et al. on HPLC/FPLC transferability) are context for how identity and chromatography are discussed. They are not a substitute for the lot COA. An HPLC area-percent figure is an analytical attribute under the stated method. Do not convert it into a human-use claim.

Identity

Form

Lyophilized powder, sealed vial

Strength

10 mg, 20 mg, 30 mg lyophilized vials

Purity

HPLC area percent on the lot COA

CAS

  • Retatrutide: 2381089-83-2

PubMed

Selected literature

  • PMID 42745421 (2026) Carneiro et al., Rapid Communications in Mass Spectrometry — LC-HRMS detection / excretion profile of retatrutide (analytical context)
  • PMID 41667417 (2026) Streuli et al., Journal of Peptide Science — HPLC/FPLC analysis transferability notes for peptide purification / analysis

Literature is scientific context only. A paper does not make a research vial into a licensed medicine.

Bench reconstitution

Identity and purity checks come before reconstitution. Dissolve the cake in bacteriostatic water only after the lot, HPLC area percent, and mass-spec identity agree with the receiving record.

Diluent page: bacteriostatic water.

Storage

Keep the lyophilized vial at 2–8 °C, protected from light and moisture, until the bench protocol calls for it. After reconstitution, hold at 2–8 °C; use within the sterility window your laboratory controls allow. Do not freeze–thaw repeatedly. Record open date and concentration in the notebook. Confirm the lot COA before you adopt a hold time.

Certificate of analysis

Every product has a View COA button. Where the lot certificate of analysis (identity and HPLC purity) is posted, it opens the certificate with a PDF download. Where it is not posted yet, the same button sends a request by email to request@pharmapeptidesrx.com, or you can write that address with the SKU. This page is not a COA.

Lab FAQ

Is an HPLC area-percent figure a clinical-grade claim?

No. It is an analytical attribute under the stated method for research-use-only material. Write request@pharmapeptidesrx.com and ask for the lot-matched COA on the named strength. This page does not publish prices or banking details. Invoices go out from request@ only.

In this library

In stock · list price

Request from the catalog

Every vial on the catalog shows its CAD list price. Add it to your request and we email the invoice. Labs pay by Interac e-Transfer. No card checkout.